HBOT mobilises the body's own progenitor cells — but those cells age with the patient. MSC delivers an external signal that does not.

The 24–48 hour post-session window captures the SDF-1 homing peak. Injecting outside it is a predictable underperformance.

Post-injection HBOT protects newly administered cells during the engraftment window.

Which patients on your current HBOT list are the clearest candidates right now.

The post-EBOO microenvironment has the lowest inflammatory resistance of any delivery window in clinical practice.

Injecting biologics before the environment is cleared produces a predictable reduction in effect.

Which ozone modality belongs at which stage — and why resuming EBOO immediately after biologic administration works against the protocol.

NAD⁺ restores energy capacity. It does not deliver repair instructions. MSC does.

NAD⁺ pre-loading 24–48 hours before biologic administration produces the highest-readiness recipient cells. The reverse order reduces effect.

PlaqX membrane preparation is a prerequisite — not optional — in metabolic and cardiovascular patients.

Peptide signalling lasts hours to days. Structural remodelling takes weeks to months. MSC closes that gap.

BPC-157 given 5–7 days before MSC administration upregulates the receptors that biologic cargo will activate.

Practitioners running CJC-1295/Ipamorelin for 6–8 weeks before orthopaedic MSC injection are already running half a biologic protocol.

Antioxidants protect cells from today's damage. MSC and exosomes reprogram cells to produce less damage tomorrow. Both are necessary. Neither alone is sufficient.

High-dose glutathione given simultaneously with MSC injection suppresses the paracrine signalling MSC needs to function. A 24–48 hour separation makes it a benefit instead.

CoQ10 IV before MSC injection is a high-priority step in patients on statin therapy — and routinely missed.